NCT05121415View on ClinicalTrials.gov

Investigation of Genetic Disease Marker Associated With Spontaneous Haemorrhagic Stroke Complicating Severe Pre-eclampsia in Pregnancy

CompletedOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

October 23, 2021

Primary Completion Date

January 20, 2023

Study Completion Date

January 20, 2023

Conditions

Hemorrhagic StrokeEclampsia

Interventions

GENETIC

SNP analysis of the DNA

SNP analysis of the DNA obtained from peripheral blood sample

Trial Locations (1)

Unknown

Hospital, Almaty

All Listed Sponsors

lead

Asfendiyarov Kazakh National Medical University

OTHER

NCT05121415 - Investigation of Genetic Disease Marker Associated With Spontaneous Haemorrhagic Stroke Complicating Severe Pre-eclampsia in Pregnancy | Biotech Hunter | Biotech Hunter